Expectations of global regulators are increasing regarding ongoing, long-term safety assessments, signal detection, and refinement. The right strategy to continually evaluate product safety in your clinical trials, through regulatory review and entering the post-marketing setting is complex. Local market regulations are ever-changing. Technologies to intake, track, and manage workflow are getting more sophisticated.
Download our Global Pharmacovigilance Readiness Checklist to guide internal conversations around your organization’s safety strategies:
Complete the form below to receive your complimentary copy of the checklist